ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses

Jing et al.
Journal of Hepatology
Papers
January 2016
Authors and Affiliates
Jing L#1, Laing KJ#1, Dong L1, Russell RM1, Barlow RS2, Haas JG3,4, Ramchandani MS1, Johnston C1, Buus S5, Redwood AJ6, White KD7, Mallal SA6,7, Phillips EJ6,7, Posavad CM8,9, Wald A1,10,8,9, Koelle DM1,2,8,9,11. 1 Department of Medicine, University of Washington, Seattle, USA. 2 Department of Global Health, University of Washington, Seattle, USA. 3 Max von Pettenkofer-Institute, Munich, Germany. 4 Division of Pathway Medicine, University of Edinburgh, United Kingdom. 5 Laboratory of Experimental Immunology, University of Copenhagen, Copenhagen, Denmark. 6 Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia. 7 Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA. 8 Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, USA. 9 Department of Laboratory Medicine, University of Washington, Seattle, USA. 10 Department of Epidemiology, University of Washington, Seattle, USA. 11 Benaroya Research Institute, Seattle, USA. # Contributed equally.